Bladder Cancer Industry, March 2015 Market Reports from Top Publishers

You might be interested in: Diagnostics, Oncology, Drug, Biomarker, Clinical Trial.


 
1-10 of 20 reports for Bladder Cancer

Purchase Reports From Reputable Market Research Publishers

Bladder Cancer Partnering 2010-2015

Bladder Cancer Partnering 2010-2015

  • $ 795
  • Industry report
  • March 2015
  • by Currentpartnering

The Bladder Cancer Partnering 2010-2015 report provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in ...

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Bladder Cancer Drug Pathway Analyzer 2015

Bladder Cancer Drug Pathway Analyzer 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 110 targeted molecular therapies known to affect more than 216 specific intracellular signaling pathways ...

Bladder Cancer Drug Pipeline Update 2015

Bladder Cancer Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

According to the American Cancer Society, bladder cancer is the 6th most common cancer in the U.S. Bladder cancer occurs among both men and women. When found and treated early, the 5 year survival rate ...

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2014, Global Markets Direct

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2014, Global Markets Direct

  • $ 2 000
  • Industry report
  • September 2014
  • by Global Markets Direct

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladde ...

 Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2014

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“ Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of ...

 Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2014

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight’s,“ Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this ...

Bladder Cancer - Pipeline Review, H2 2014

Bladder Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Global Markets Direct

Bladder Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H2 2014’, provides an overview of the Bladder Cancer’s therapeutic pipeline. This report ...

 Bladder Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Bladder Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight’s, “ Bladder Cancer- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

Bladder Cancer Treatment Drugs Markets in China

Bladder Cancer Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • May 2014
  • by Asia Market Information & Development Company

China's demand for bladder cancer treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's ...

About 1 500 reports for Bladder Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2014
    42 pages
  • Cancer  

    Oncology  

    Bladder Cancer  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.